VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce that Technology Networks Drug Discovery, in its September 1, 2023 issue…

Source

Previous articleCalifornia Psychedelic Decriminalisation Bill Clears Appropriations Committee with Amendments
Next articleOptimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing